Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Tralokinumab in the Skin: an Immunologic and Molecular Investigation (TRALIS)

NCT05378698 is registered in ClinicalTrials.gov with University of Zurich as lead sponsor.

NCT NCT05378698
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05378698 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Tralokinumab in the Skin: an Immunologic and Molecular Investigation (TRALIS)
Lead sponsor
University of Zurich
Phase
Phase 2/3
Overall status
Terminated
Start date
June 15, 2022
Completion date
March 4, 2025
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis